glp 1 rfk Jr Ozempic rfk and glp 1 Whoopi

N Engl J Med (2012) 366(17):157785.10.1056/NEJMoa1200111 13 SchauerPRKashyapSRWolskiKBrethauerSAKirwanJPPothierCEet alBariatric surgery versus intensive medical therapy in obese patients with diabetes

The peptide does not appear to interact with cytochrome P450 enzymes, suggesting low potential for drug interactions

Those are legitimate, if modest, reasons a supervised program might include it and they are very different from the marketed promise of an injection that melts fat. Potential Benefits & Side Effects What the literature actually supports is ingredient-level biochemistry plus uncontrolled clinical use not controlled human trials of the finished injection for fat loss

Immunogenetics 46 , 484492 (1997)

10.1038/s41586-021-03539-7 80